RAPIBLYK

LANDIOLOL · AOP Orphan Pharmaceuticals GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RAPIBLYK, covering 2024-11-22 to 2026-02-13. Get the full timeline:

Most recent: FDA Approved: RAPIBLYK — Supplemental Application (AOP Orphan Pharmaceuticals GmbH)